Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient

The choice of second-line chemotherapy in patients with recurrent ovarian cancer (ROC) is complex, with several factors to be considered, the most important of which is the length of the platinum-free treatment interval (PFI). Recently ROC patients have been further stratified into platinum sensitiv...

Descripción completa

Detalles Bibliográficos
Autor principal: Colombo, Nicoletta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683383/
https://www.ncbi.nlm.nih.gov/pubmed/26759526
http://dx.doi.org/10.1016/S1359-6349(15)70004-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683383/
https://www.ncbi.nlm.nih.gov/pubmed/26759526
http://dx.doi.org/10.1016/S1359-6349(15)70004-2

Ejemplares similares